Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms

Wataru Yamagami, Mikio Mikami, Satoru Nagase, Tsutomu Tabata, Yoichi Kobayashi, Masanori Kaneuchi, Hiroaki Kobayashi, Hidekazu Yamada, Kiyoshi Hasegawa, Hiroyuki Fujiwara, Hidetaka Katabuchi, Daisuke Aoki

Research output: Contribution to journalArticle

Abstract

The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for endometrial cancer, 3. Postoperative adjuvant therapy for endometrial cancer, 4. Post-treatment surveillance for endometrial cancer, 5. Treatment for advanced or recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment of uterine carcinosarcoma and uterine sarcoma, 8. Treatment of trophoblastic disease, 9. Document collection; and nine algorithms: 1-3. Initial treatment of endometrial cancer, 4. Postoperative adjuvant treatment for endometrial cancer, 5. Treatment of recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment for uterine carcinosarcoma, 8. Treatment for uterine sarcoma, 9. Treatment for choriocarcinoma. Each chapter includes overviews and clinical questions, and recommendations, objectives, explanation, and references are provided for each clinical question. This revision has no major changes compared to the 3rd edition, but does have some differences: 1) an explanation of the recommendation decision process and conflict of interest considerations have been added in the overview, 2) nurses, pharmacists and patients participated in creation of the guidelines, in addition to physicians, 3) the approach to evidence collection is listed at the end of the guidelines, and 4) for clinical questions that lack evidence or clinical validation, the opinion of the Guidelines Committee is given as a "Recommendations for tomorrow".

Original languageEnglish
Pages (from-to)e18
JournalJournal of gynecologic oncology
Volume31
Issue number1
DOIs
Publication statusPublished - 2020 Jan 1

Fingerprint

Uterine Neoplasms
Japan
Guidelines
Endometrial Neoplasms
Therapeutics
Carcinosarcoma
Sarcoma
Fertility
Conflict of Interest
Choriocarcinoma
Pharmacists

Keywords

  • Clinical Practice Guideline
  • Endometrial Cancer
  • Gestational Trophoblastic Disease
  • Treatment
  • Uterine Sarcoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms. / Yamagami, Wataru; Mikami, Mikio; Nagase, Satoru; Tabata, Tsutomu; Kobayashi, Yoichi; Kaneuchi, Masanori; Kobayashi, Hiroaki; Yamada, Hidekazu; Hasegawa, Kiyoshi; Fujiwara, Hiroyuki; Katabuchi, Hidetaka; Aoki, Daisuke.

In: Journal of gynecologic oncology, Vol. 31, No. 1, 01.01.2020, p. e18.

Research output: Contribution to journalArticle

Yamagami, W, Mikami, M, Nagase, S, Tabata, T, Kobayashi, Y, Kaneuchi, M, Kobayashi, H, Yamada, H, Hasegawa, K, Fujiwara, H, Katabuchi, H & Aoki, D 2020, 'Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms', Journal of gynecologic oncology, vol. 31, no. 1, pp. e18. https://doi.org/10.3802/jgo.2020.31.e18
Yamagami, Wataru ; Mikami, Mikio ; Nagase, Satoru ; Tabata, Tsutomu ; Kobayashi, Yoichi ; Kaneuchi, Masanori ; Kobayashi, Hiroaki ; Yamada, Hidekazu ; Hasegawa, Kiyoshi ; Fujiwara, Hiroyuki ; Katabuchi, Hidetaka ; Aoki, Daisuke. / Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms. In: Journal of gynecologic oncology. 2020 ; Vol. 31, No. 1. pp. e18.
@article{f438dfedcac34a4cb59a1d8e38c3e728,
title = "Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms",
abstract = "The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for endometrial cancer, 3. Postoperative adjuvant therapy for endometrial cancer, 4. Post-treatment surveillance for endometrial cancer, 5. Treatment for advanced or recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment of uterine carcinosarcoma and uterine sarcoma, 8. Treatment of trophoblastic disease, 9. Document collection; and nine algorithms: 1-3. Initial treatment of endometrial cancer, 4. Postoperative adjuvant treatment for endometrial cancer, 5. Treatment of recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment for uterine carcinosarcoma, 8. Treatment for uterine sarcoma, 9. Treatment for choriocarcinoma. Each chapter includes overviews and clinical questions, and recommendations, objectives, explanation, and references are provided for each clinical question. This revision has no major changes compared to the 3rd edition, but does have some differences: 1) an explanation of the recommendation decision process and conflict of interest considerations have been added in the overview, 2) nurses, pharmacists and patients participated in creation of the guidelines, in addition to physicians, 3) the approach to evidence collection is listed at the end of the guidelines, and 4) for clinical questions that lack evidence or clinical validation, the opinion of the Guidelines Committee is given as a {"}Recommendations for tomorrow{"}.",
keywords = "Clinical Practice Guideline, Endometrial Cancer, Gestational Trophoblastic Disease, Treatment, Uterine Sarcoma",
author = "Wataru Yamagami and Mikio Mikami and Satoru Nagase and Tsutomu Tabata and Yoichi Kobayashi and Masanori Kaneuchi and Hiroaki Kobayashi and Hidekazu Yamada and Kiyoshi Hasegawa and Hiroyuki Fujiwara and Hidetaka Katabuchi and Daisuke Aoki",
year = "2020",
month = "1",
day = "1",
doi = "10.3802/jgo.2020.31.e18",
language = "English",
volume = "31",
pages = "e18",
journal = "Journal of Gynecologic Oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "1",

}

TY - JOUR

T1 - Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms

AU - Yamagami, Wataru

AU - Mikami, Mikio

AU - Nagase, Satoru

AU - Tabata, Tsutomu

AU - Kobayashi, Yoichi

AU - Kaneuchi, Masanori

AU - Kobayashi, Hiroaki

AU - Yamada, Hidekazu

AU - Hasegawa, Kiyoshi

AU - Fujiwara, Hiroyuki

AU - Katabuchi, Hidetaka

AU - Aoki, Daisuke

PY - 2020/1/1

Y1 - 2020/1/1

N2 - The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for endometrial cancer, 3. Postoperative adjuvant therapy for endometrial cancer, 4. Post-treatment surveillance for endometrial cancer, 5. Treatment for advanced or recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment of uterine carcinosarcoma and uterine sarcoma, 8. Treatment of trophoblastic disease, 9. Document collection; and nine algorithms: 1-3. Initial treatment of endometrial cancer, 4. Postoperative adjuvant treatment for endometrial cancer, 5. Treatment of recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment for uterine carcinosarcoma, 8. Treatment for uterine sarcoma, 9. Treatment for choriocarcinoma. Each chapter includes overviews and clinical questions, and recommendations, objectives, explanation, and references are provided for each clinical question. This revision has no major changes compared to the 3rd edition, but does have some differences: 1) an explanation of the recommendation decision process and conflict of interest considerations have been added in the overview, 2) nurses, pharmacists and patients participated in creation of the guidelines, in addition to physicians, 3) the approach to evidence collection is listed at the end of the guidelines, and 4) for clinical questions that lack evidence or clinical validation, the opinion of the Guidelines Committee is given as a "Recommendations for tomorrow".

AB - The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for endometrial cancer, 3. Postoperative adjuvant therapy for endometrial cancer, 4. Post-treatment surveillance for endometrial cancer, 5. Treatment for advanced or recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment of uterine carcinosarcoma and uterine sarcoma, 8. Treatment of trophoblastic disease, 9. Document collection; and nine algorithms: 1-3. Initial treatment of endometrial cancer, 4. Postoperative adjuvant treatment for endometrial cancer, 5. Treatment of recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment for uterine carcinosarcoma, 8. Treatment for uterine sarcoma, 9. Treatment for choriocarcinoma. Each chapter includes overviews and clinical questions, and recommendations, objectives, explanation, and references are provided for each clinical question. This revision has no major changes compared to the 3rd edition, but does have some differences: 1) an explanation of the recommendation decision process and conflict of interest considerations have been added in the overview, 2) nurses, pharmacists and patients participated in creation of the guidelines, in addition to physicians, 3) the approach to evidence collection is listed at the end of the guidelines, and 4) for clinical questions that lack evidence or clinical validation, the opinion of the Guidelines Committee is given as a "Recommendations for tomorrow".

KW - Clinical Practice Guideline

KW - Endometrial Cancer

KW - Gestational Trophoblastic Disease

KW - Treatment

KW - Uterine Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85076448657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076448657&partnerID=8YFLogxK

U2 - 10.3802/jgo.2020.31.e18

DO - 10.3802/jgo.2020.31.e18

M3 - Article

C2 - 31789001

AN - SCOPUS:85076448657

VL - 31

SP - e18

JO - Journal of Gynecologic Oncology

JF - Journal of Gynecologic Oncology

SN - 2005-0380

IS - 1

ER -